Q3 2020 Coloplast A/S Earnings Call Transcript
/-&
Good afternoon, and welcome to our third quarter '19/'20 conference call. I'm Kristian Villumsen, CEO of Coloplast, and I'm joined by CFO, Anders Lonning-Skovgaard and our Investor Relations team. We'll start with a short presentation by Anders and myself and then open up for questions.
I'd like to start by thanking all of our employees at Coloplast, who serve users and our clinician partners every day during these challenging times of a global pandemic. As a company, our priorities during COVID have remained clear to keep our people safe, continue to serve our customers and maintain business operations. We've done this throughout the COVID-19 pandemic, and I'm very pleased with that.
Please turn to Slide #3. Before I dive into today's results, I'd like to zoom out and talk about the next 5 years for a minute. We're currently in the process of finalizing our 2025 strategy, which will be launched at our Capital Markets Day at the end of September. And at the core of the new strategy are
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
